Nationwide Trends in Inpatient Admissions of Pulmonary Hypertension in the United States from 2000 to 2013

Abstract

Introduction: Pulmonary Hypertension (PH) is a disorder of the pulmonary vasculature with high mortality and bears a large economic burden on the healthcare system. We conducted a review of the largest inpatient database in the United States and analyzed the trends in hospitalizations due to PH from the turn of the century (2000) to 2013 to evaluate the rate of hospitalizations and determine the cost and mortality associated with PH. Conclusion:The number of inpatient discharges related to PH has increased even though the number of inpatient discharges with PAH has been reported to be lower in literature. The mean length of stay has also shown a mild increase. This increase is associated with a significant increase in the mean and aggregate cost. These inpatient costs associated with PH contribute significantly to the total healthcare burden. Further research on cost-effective evaluation and management of PH is required.

In-Hospital Outcomes of Patients With Pulmonary Hypertension and Cirrhosis: A 6-Year Population Cohort Study of Over One Million Patients

“…In patients with pulmonary hypertension, recent studies have reported a 13% increase in hospital LOS (11.8 days longer), initial diagnosis at an older age (> 65 years), a small percentage patients with private insurance, doubled hospital charges, and a 23% decrease in mortality [ 8 ]. Mortality has decreased due to advancements in treatment and the new pharmacotherapies that are now available.…”

PH Professional Network: Bridging the Gap: A Multidisciplinary Approach to Transitions of Care

“…2 Using the National Inpatient Sample Database to identify PH or cor pulmonale as the primary discharge diagnosis from 2000 to 2013, the authors found increased admissions for PH in terms of absolute numbers, mean length of stay, and hospital charges. 3,4 In fact, the overall cost of hospital visits of a patient increased by 209.5% from $301,324,218 in 2000 to $932,554,725 in 2013. 4 These inpatient costs associated with PH contribute significantly to the total health care burden.…”

“…3,4 In fact, the overall cost of hospital visits of a patient increased by 209.5% from $301,324,218 in 2000 to $932,554,725 in 2013. 4 These inpatient costs associated with PH contribute significantly to the total health care burden. With advances in PH treatment options and increased use of combination therapy, medication costs are rising.…”

Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function

“…PH is under-diagnosed and diagnosis is often made late with a median survival of only 2.8 years [ 12 ]. A diagnosis of PH also increases the cost of inpatient admissions; a study found that the aggregate cost of hospital visits of a patient in the United States with the principal diagnosis of PH increased 209.5% from $301,324,218 in 2000 to $932, 554, 725 in 2013 [ 13 ].…”